Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Ford Investor Services, Inc.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Ocular Therapeutix Inc prices initial public offering


Thursday, 24 Jul 2014 10:30pm EDT 

Ocular Therapeutix Inc:Says pricing of its initial public offering of 5,000,000 shares of its common stock at a public offering price of $13 per share, before underwriting discounts and commissions.Says all of the shares in the offering are being sold by Ocular.Ocular's common stock has been approved for listing on the NASDAQ Global Market and is expected to begin trading under the ticker symbol "OCUL" on July 25, 2014.Says in addition, Ocular has granted the underwriters an option for a period of 30 days to purchase, at the public offering price less the underwriting discount, up to 750,000 additional shares of common stock to cover over-allotments.Says Morgan Stanley & Co., Cowen and Company and RBC Capital Markets are acting as joint book-running managers.Says Oppenheimer & Co. is acting as a co-manager.